Navigation Links
Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors
Date:5/20/2008

CHENGDU, China, May 20 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it signed over 60 new distribution agreements with a total of 15 regional distributors, including both new and previously contracted distributors.

Many of these agreements, which are for a term of one year, were signed with several of the Company's top 10 distributors from 2007. Newly engaged distributors include Sichuan Kelun Medicine & Trade Co., Ltd. and Zhejiang Huadong Medicine Co., Ltd. Based upon the results of previous years' agreements, and expected results from the new agreements, management believes that all of the 2008 distribution agreements have the potential to generate over an aggregate of $10 million in product orders, which would represent a 20% increase over the results received from last year's distribution agreements.

The distribution agreements cover 27 existing products from last year's agreements and 1 newly launched drug, the Azithromycin Dispersible Tablet, which is used for Upper and lower respiratory tract infections and other bacterial infections in the skin and reproductive system. The Company's two flagship products, Arpu Shuangxin Oral Liquid and Ginkgo Mihuan Oral Liquid, along with any other new drugs that we launch during 2008 are not included in the distribution agreements discussed herein.

"This accomplishment is significant for several reasons and demonstrates Tianyin Pharmaceutical's ability to expand its geographic footprint and distribution channels for both existing and new products. This will help us to gain incremental market share, which will ultimately drive future revenue growth. We recently initiated production to fulfill orders for the 28 products referenced above and anticipate initial contribution from these agreements during the fourth quarter of f
'/>"/>

SOURCE Tianyin Pharmaceutical, Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
2. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT
4. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results
5. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
10. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... State College, PA (PRWEB) June 18, 2013 ... six months, produces increased fluid retention through the tip ... collected using the Salimetrics Infant Swab (SIS) ... CRP, IL-1beta and Chromogranin A. , The diameter of ... mm. This allows the new swab to access more ...
(Date:6/17/2013)... Brook, IL (PRWEB) June 17, 2013 ... found that two MRI measurements of the abdominal aorta ... the thickness of its wall — are associated with ... stroke. Results of the study are published online in ... because it demonstrates that atherosclerosis in an artery outside ...
(Date:6/17/2013)... study of more than 2,000 adults, researchers found that ... amount of plaque in the vessel and the thickness ... events, such as a heart attack or stroke. Results ... Radiology . , "This is an important study, ... the heart is an independent predictor of adverse cardiovascular ...
(Date:6/17/2013)... Daimer Industries, Inc.®, a well-renowned U.S. based ... as expertly designed carpet steam cleaner and vapor steam ... for apartment dwellers and homeowners. The commercial steam cleaner ... and pressure levels up to 75 psi to clean ... to clean carpet spots and areas in homes, but ...
(Date:6/17/2013)... York (PRWEB) June 17, 2013 Lawsuits ... products manufactured by C.R. Bard, Inc. continue to move ... Jersey’s Atlantic County Superior Court, Bernstein Liebhard LLP reports. ... Order that set forth protocols for the preservation and ... litigation’s bellwether cases. Court documents indicate that the ...
Breaking Medicine News(10 mins):Health News:Salimetrics Redesigns Infant Swab for Faster, Easier Collection 2Health News:RSNA: Atherosclerosis in Abdominal Aorta May Signal Future Heart Attack, Stroke 2Health News:RSNA: Atherosclerosis in Abdominal Aorta May Signal Future Heart Attack, Stroke 3Health News:Atherosclerosis in abdominal aorta may signal future heart attack, stroke 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples 3
... By Steven Reinberg HealthDay Reporter , TUESDAY, Jan. ... the United States as it is in other developed countries, ... rates of smoking and obesity. For 25 years, U.S. ... than in most of the other 21 countries studied, including ...
... experienced hot flushes and other symptoms of menopause may have ... forms of breast cancer than postmenopausal women who have never ... at Fred Hutchinson Cancer Research Center. , The results of ... and breast cancer risk are available online ahead of the ...
... HealthDay Reporter , TUESDAY, Jan. 25 (HealthDay News) -- It,s ... off over the long-term is even tougher. But obese children ... and exercise lost weight and kept it off for the ... Researchers said the study shows that targeting parents -- rather ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... of external defibrillators, the U.S. Food and Drug Administration is ... devices be held to stricter standards. Over the past ... defibrillators, which are used to shock a patient in cardiac ...
... friendly bartender can be the source of more than just ... that some bartenders may be in a good position to ... connect them to the appropriate agency. Researchers at Ohio ... Wars posts in Ohio. The results showed that bartenders ...
... large supplies of safe and reliable human embryonic stem ... the field has faced challenges in developing cultures that ... Standard culture systems use mouse "feeder" cells ... hES cells, but such animal productbased media can contaminate ...
Cached Medicine News:Health News:Smoking, Obesity Slowing U.S. Life Expectancy Gains: Report 2Health News:Smoking, Obesity Slowing U.S. Life Expectancy Gains: Report 3Health News:Hot flushes are linked with a significant reduction in breast cancer risk 2Health News:Changing Parental Behavior May Help Obese Kids Lose Weight 2Health News:Changing Parental Behavior May Help Obese Kids Lose Weight 3Health News:FDA Looking at Tougher Standards for External Defibrillators 2Health News:Bartenders may have role in assisting troubled war veterans 2Health News:Bartenders may have role in assisting troubled war veterans 3Health News:UCLA researchers eliminate major roadblock in regenerative medicine 2Health News:UCLA researchers eliminate major roadblock in regenerative medicine 3
(Date:6/17/2013)... Franciscan St. Francis Health Cancer Center today (June ... to use a new drug to treat men ... Xofigo ®, a radiopharmaceutical used in patients with late-stage, metastatic ... approved for use by the U.S. Food and Drug Administration. ... may become castration-resistant, which has become resistant to medical or ...
(Date:6/17/2013)... June 17, 2013  Today BioSpace , the leading ... BioCapital Hotbed map campaign spotlighting the life sciences community ... , Delaware and Washington ... ) The BioCapital area continues to ... BioSpace.com average 21 applies each - a strong ...
(Date:6/17/2013)... 2013 Actavis, Inc. (NYSE: ACT ) ... the decision of the U.S. Court of Appeals for the ... Actavis, motion to dismiss the Federal Trade Commission,s lawsuit, ... the result of a decision by a 5 to 3 ... and adopted the traditional "rule of reason" as the standard.  ...
Breaking Medicine Technology:New drug proving effective in attacking advanced prostate cancer 2Mid-Atlantic Biotech Leaders Featured On BioSpace Map 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3
... published in the American Journal of Nephrology -, ... announced that its Phase III data on VAPRISOL was ... Nephrology. In this study,VAPRISOL showed a significant increase in ... life-threatening condition that,occurs when the body,s sodium level falls ...
... Cancer patients at Beaumont,Hospitals are the first in the ... therapy that is painless, faster, more accurate and precise,than ... patented the new,technology, Omnibeam(R). The $3.3-million machine is manufactured ... first patient,was treated on Sept. 10. The painless ...
Cached Medicine Technology:Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 2Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 3Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 5Beaumont Patients 1st to get Next Generation of Radiation Treatment 2
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support....
15mm Open Blades, 28mm Maximum Spread; Available in small(S) and large (L), in stainless steel....
Phaco Chopper, double ended; a combination of a modified MicroFinger and a pointed "quick chop" tip, in titanium...
0.5X1.5mm Tip, Oval Shape; in Titanium....
Medicine Products: